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A B S T R A C T
Many traditional fermented products are onsumed in Ishikawa Prefecture, Japan, such as kaburazushi,
narezushi, konkazuke, and ishiru. Various kinds of lactic acid bacteria (LAB) are associated with their
fermentation, however, characterization of LAB has not yet been elucidated in detail. In this study, we
evaluated 53 isolates of LAB from various traditional fermented foods by taxonomic classiﬁcation at the
species level by analyzing the 16S ribosomal RNA gene (rDNA) sequences and carbohydrate assimilation
abilities. We screened isolates that exhibited high angiotensin-converting enzyme (ACE) inhibitory
activities in skim milk or soy protein media and produced high g-aminobutyric acid (GABA)
concentrations in culture supernatants when grown in de Man Rogosa Sharpe broth in the presence
of 1% (w/v) glutamic acid. The results revealed that 10 isolates, i.e., Lactobacillus buchneri (2 isolates),
Lactobacillus brevis (6 isolates), and Weissella hellenica (2 isolates) had a high GABA-producing ability
of >500 mg/100 ml after 72 h of incubation at 35 C. The ACE inhibitory activity of the whey cultured with
milk protein by using L. brevis (3 isolates), L. buchneri (2 isolates), and W. hellenica (2 isolates) was
stronger than that of all whey cultured with soy protein media, and these IC50 were < 1 mg protein/ml.
Three of 10 isolates had high GABA-producing activities at pH 3, suggesting that they could be powerful
candidates for use in the fermentation of food materials having low pH.
ã 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Ishikawa Prefecture in the Hokuriku region, which is located in
the northern part of central Japan, is one of the major areas in
which people produce various fermented ﬁsh products, such as
fermented ﬁsh with cooked rice (narezushi), fermented ﬁsh and
vegetable with malted rice (kaburazushi), ﬁsh fermented with rice
bran mash (konkazuke), and ﬁsh sauce (ishiru). These products are
known to be lactic acid fermented foods, in which various lactic
acid bacteria (LAB) are involved in the production process [1–5].* Corresponding author at: Department of Food Science, Ishikawa Prefectural Univer
E-mail address: enomoto@ishikawa-pu.ac.jp (T. Enomoto).
http://dx.doi.org/10.1016/j.btre.2016.04.002
2215-017X/ã 2016 The Authors. Published by Elsevier B.V. This is an open access article unTill date, many studies have demonstrated that several LAB
species produce a ubiquitous four-carbon amino acid, g-amino-
butyric acid (GABA), which is synthesized from glutamic acid via a
reaction catalyzed by glutamate decarboxylase [EC 4.1.1.15], a
pyridoxal 50-phosphate-dependent enzyme [6]. In mammals,
GABA has various physiological functions, such as neurotransmis-
sion and the induction of hypotensive effects [7]. It is well known
that it is involved in the regulation of cardiovascular functions such
as blood pressure and heart rate, and that it plays an important role
in the sensations of pain and anxiety [8]. In addition, GABA is foundsity, 1-308 Suematsu, Nonoichi, Ishikawa 921-8836, Japan.
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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reported that GABA intake can help treat various neurological
disorders such as Parkinson’s disease, stiff-man syndrome, and
schizophrenia. Although GABA is present in many fruits and
vegetables, the amount of GABA present is very low, ranging from
0.03–2.00 mmol/g fresh weight [11]. Therefore, the development of
new pharmaceutical and functional foods containing a consider-
able amount of GABA is required. Many studies have reported the
mass production of GABA using Lactobacillus brevis isolated from
alcohol distillery lees [12] and kimchi [13], Lactobacillus paracasei
from fermented ﬁsh [14], and Lactococcus lactis from cheese
starters [15].
Moreover, people have become increasingly interested in
functional foods, because of a growing awareness among
consumers of the link between diet and health. Angiotensin I-
converting enzyme (ACE) [EC 3.4.15.1], a dipeptidyl carboxypepti-
dase, plays an important role in the regulation of blood pressure,
and the enzyme cleaves the dipeptide portion from the C-terminal
end of angiotensin I to produce the strong vasopressor angiotensin
II. Hence, great interest has been shown in ACE-inhibitory peptides
that have the ability to lower the blood pressure of hypertensive
patients. Various ACE-inhibitory peptides have been isolated from
different sources that are released during or after fermentation
[16–19] or by hydrolytic processes [20].Table 1
LAB isolated from the fermented foods of Ishikawa Prefecture, Japan.
Fermented foods Origin Raw materials 
Narezushi Purchased from
market
Fish (horse mackerel, mackerel, or amberjac






Fish (horse mackerel), rice, Japanese pepper
Ika-koujizuke Purchased from
market
Squid and malted rice 
Ika-kurozukuri Purchased from
market
Squid and squid ink 
Kaburazushi Made by
manufacturer
Yellow tail, turnip, and malted rice 
Daikonzushi Made by
manufacturer
Herring, Japanese radish, and malted rice 
Yamahai-syubo Made by
manufacturer
Malted rice and cooked rice 
a Identiﬁed by 16S rDNA sequence analyses.The aim of this study was to screen various LAB exhibiting a
strong ability to produce GABA and ACE inhibitors, which are
expected to enhance the development of functional fermented
foods. We tested both these abilities in LAB isolated from
traditional fermented foods of Ishikawa Prefecture that were
cultured in the presence of skim milk or soy protein. Based on this
study, we discussed the possibility of these isolates being used as
starters in the production of new types of fermented foods.
2. Materials and methods
2.1. Media and chemicals
De Man Rogosa Sharpe (MRS) medium was purchased from
Oxoid (Basingstoke, Hampshire, UK). An API 50CH test kit was
purchased from bioMérieux, Marcy l’Etoile, France. GABase (a
mixture of g-aminobutyrate glutamate aminotransferase and
succinic semialdehyde dehyrogenase from Pseudomonas ﬂuores-
cens) was purchased from Sigma-Aldrich (St Louis, MO, USA). NADP
+ was purchased from Oriental Yeast Co. (Tokyo, Japan). GABA,
dithiotheriol, a-ketoglutarate, tris (hydroxymethyl) aminome-
thane (Tris), and sodium sulfate were obtained from Nakalai
Tesque Inc. (Kyoto, Japan). Glutamic acid was purchased from
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LAB were isolated by spreading 101–104-fold diluted samples of
variousfermentedfoodsof IshikawaPrefectureontoMRSagarplates.
Nine narezushi made from aji (horse mackerel, Trachurus japonicus),
saba (mackerel, Scomber japonicus), or buri (amberjack, Seriola
quinqueradiata) were purchased from different markets in Noto
Peninsula, Ishikawa, Japan. Of 53 isolates shown in Table 1, ﬁve LAB
were isolated in our previous work, and the Lactobacillus brevis
strain ANP7-6 was isolated from aji-narezushi in that study
(GenBank accession code AB666315) [21]. One ika-koujizuke (squid
fermented with malted rice) and one ika-kurozukuri (squid
fermented with squid ink) samples were also purchased from
markets in Noto. Kaburazushi and daikonzushi were produced by
Shijimaya-Hompo (Kanazawa, Ishikawa, Japan), while yamahai-
shubo (a yeast mash used as a starter for Japanese sake) was
produced by Syata-Shuzo (Hakusan, Ishikawa, Japan). Kaburazushi,
daikonzushi, and yamahai-shubo were fermented in single tanks and
the samples were withdrawn at various time points for isolation of
LAB. From each fermented food sample, at least 5 colonies were
randomly selected and used for species identiﬁcation. Isolated
colonies were streaked twice and stored in liquid culture at 80 C
in the presence of 15%–20% (v/v) glycerol.Details of the isolates from
each food are summarized in Table 1.
2.3. Sequence analyses of the 16S ribosomal RNA genes
Genomic DNA was extracted from LAB cells using a Wizard
Genomic DNA Extraction Kit (Promega, Madison, WI, USA). The
entire 16S ribosomal RNA genes (rDNA) were ampliﬁed using the
oligonucleotides F8 (50-AGAGTTTGATCATGGCTCAG-30) and R1510
(50-ACGGYTACCTTTGTTACGACTT-30) as a primer pair and the
respective genomic DNA as templates. PCR was performed using
ExTaq DNA polymerase (Takara, Shiga, Japan) with 25 cycles of
denaturation (96 C, 15 s), annealing (50 C, 15 s), and extension
(72 C, 1 min and 30 s). The ampliﬁed fragments were puriﬁed
using a QIAquick PCR puriﬁcation Kit (Qiagen, Venlo, Netherlands)
to remove the residual primers and were then used as templates in
the next cycle for direct DNA sequencing. The sequence analysis
was performed using a BigDye Terminator v3.1Cycle Sequencing
Kit and an ABI 3130  1 Genetic Analyzer (Applied Biosystems,
Foster City, CA, USA). At least 600 nucleotides that contained
multiple hypervariable regions were analyzed to determine the
taxonomic classiﬁcation of LAB isolated at the species level. The
16S rDNA sequences of L. brevis (AN 1-5, AN 2-2, AN 3-5, AN 4-5,
and SB 109), Lactobacillus buchneri (AN 1-1 and SB 21), andTable 2
LAB with high GABA-producing abilities and ACE inhibitory activities.
Strain LAB species identiﬁcation based on the 16S rRNA sequence Sequence ho
AN 1–5 L. brevis 100% 
AN 2-2 L. brevis 100% 
AN 3–5 L. brevis 100% 
AN 4–5 L. brevis 100% 
ANP 7-6 L. brevis 100% 
SB 109 L. brevis 100% 
AN 1-1 L. buchneri 100% 
SB 21 L. buchneri 100% 
SB 101 W. hellenica 100% 
SB 105 W. hellenica 100% 
a Data are the mean  SD from three independent experiments.
b nd: Not detectable.Weissella hellenica (SB 101 and SB 105) were deposited in the DNA
Data Bank of Japan under accession numbers LC136884-LC136892.
2.4. Preparation of the LAB cultures for biological tests
To identify LAB exhibiting a strong ability to produce GABA,
respective isolates were cultivated in MRS medium containing 1%
(w/v) glutamic acid at 35 C for 1–5 days (time course). The
medium was ﬁltered through a membrane ﬁlter (0.45 mm), and the
ﬁltrate was stored at 20 C until use. The amount of GABA in the
ﬁltrate was evaluated, the growth rate was determined, and the
evolution of pH was also monitored. In addition, the amount of
glutamic acid present in the medium after incubation and the
amount of lactic acid were determined (see below). To evaluate the
ability of the isolates to produce ACE inhibitors, LAB were
cultivated in media that contained 1% (w/v) skim milk or soy
protein in the presence of 10% (w/v) glucose. After fermentation,
the whey was ﬁltered (0.45 mm), and the ﬁltrate was stored at
20 C until use.
2.5. Measurement of the GABA contents
The GABA content of samples was determined by UV
spectrophotometry using GABase based on changes in absorbance
caused by the conversion of NADP+ to NADPH, as described
previously by Tsukatani et al. [22]. In brief, the reaction mixture
contained 80 mM Tris-HCl (pH 9.0), 750 mM sodium sulfate,10 mM
dithiothreitol, 1.4 mM NADP+, 2.0 mM a-ketoglutarate, and 30 mg/
ml GABase and was prepared in a total volume of 90 ml.
Subsequently, 10 ml of the standard solution (GABA) or samples
was added to initiate the reaction at 30 C for 2 h. The formation of
NADPH was measured based on the change in the absorbance at
340 nm using a microplate reader. The absorbance of the blank
prepared without GABase was spectrophotometrically measured,
and the concentrations of GABA in the samples were calculated
based on a calibration curve prepared using the standard solution.
The amount of glutamic acid present in the medium was analyzed
using a model L-8000 amino acid analyzer (Hitachi, Tokyo, Japan).
2.6. Determination of the ACE inhibitory activity
The ACE inhibitory activity was measured according to the
method described by Nakano et al. [23], with some modiﬁcations.
In brief, 0.025 U ACE (Sigma-Aldrich) was dissolved in 4.7 mM
phosphate buffer (pH 8.5). A sample (25 ml) was incubated with
the enzyme solution (50 ml) in the presence of the ACE substrate
hippuryl-L-histidyl-L-leucine (Hip-His-Leu) at room temperaturemology with type strain GABA, 96 h (mg/100 ml)a ACE inhibition(IC50)
(mg protein/ml)a
Soya Milk
616  33 2.31  0.06 0.57  0.04
558  11 9.44  0.05 ndb
499  15 1.46  0.04 nd
721  38 2.23  0.04 nd
657  10 2.81  0.11 0.83  0.32
733  43 2.36  0.08 0.63  0.04
556  44 1.33  0.04 0.73  0.02
665  27 1.59  0.06 0.64  0.04
718  33 1.37  0.02 0.28  0.01
769  21 1.42  0.04 0.42  0.02
108 F. Barla et al. / Biotechnology Reports 10 (2016) 105–110for 60 min. The reaction was then stopped by adding 0.3 M NaOH
(750 ml) and 50 ml of 2% (w/v) o-phthalaldehyde dissolved in
methanol. The mixture was kept at room temperature for 10 min,
and subsequently, 100 ml of 3 M HCl was added. After incubationFig. 1. The GABA-producing ability (ﬁlled symbols and solid lines) and utilization of gluta
and 6 (circle) during cultivation of different strains isolated from traditional fermented fo
(i)–(j) Weissella hellenica. The data points are the mean  SD from at least three indepefor 60 min at room temperature, the amount of His-Leu liberated
was determined by measuring the ﬂuorescent intensity of its
adduct with o-phthalaldehyde (excitation at 355 nm and emission
at 460 nm). The magnitude of the inhibitory effect was expressedmic acid (open symbols and dotted lines) at pH 3 (diamond), 4 (square), 5 (triangle),
ods in Ishikawa Prefecture, Japan. (a)–(f) Lactobacillus brevis, (g)–(h) L. buchneri, and
ndent experiments.
Table 3
Lactic acid production by LAB strains at different pH values.
Strain pH Lactic acid (g/L)a
12 h 48 h 96 h
AN1-5 L. brevis 3 2.6  0.2 7.9  0.4 11  1
4 3.1  0.2 19  3 21  3
5 3.4  0.2 17  1 18  2
6 3.4  0.6 19  2 22  2
AN2-2 L. brevis 3 1.4  0.1 4.0  0.3 7.3  0.5
4 2.1  0.2 19  1 15  1
5 2.0  0.2 10  1 15  1
6 2.0  0.2 9.6  0.9 12  1
AN3-5 L. brevis 3 1.2  0.1 8.4  0.4 9.1  0.3
4 1.9  0.3 11  2 11  2
5 1.7  0.3 15  2 10  3
6 2.1  0.2 9.5  0.5 11  2
AN4-5 L. brevis 3 1.3  0.4 4.0  0.6 10  0
4 1.8  0.1 12  4 11  2
5 1.9  0.6 13  3 11  3
6 1.9  1.7 12  3 18  2
ANP7-6 L. brevis 3 2.7  0.5 4.7  1.9 9.8  3.3
4 3.1  0.5 13  2 17  1
5 3.0  0.9 10  1 22  3
6 2.5  0.7 10  3 14  4
SB109 L. brevis 3 1.3  0.1 4.9  1.5 20  3
4 1.7  0.3 12  2 9.6  1.5
5 1.5  0.2 11  2 12  3
6 1.4  0.2 9.5  3.2 10  3
AN1-1 L. buchneri 3 1.0  0.2 2.3  0.5 4.9  0.7
4 1.3  0.3 5.4  0.9 9.8  1.2
5 1.2  0.1 6.3  0.8 12  2
6 1.4  0.5 5.4  0.6 18  2
SB21 L. buchneri 3 1.4  0.4 6.8  1.4 14  2
4 1.6  0.2 12  2 21  3
5 1.7  0.4 15  0 14  2
6 1.8  0.3 13  3 17  1
SB101 W. hellenica 3 1.4  0.2 1.6  0.5 4.1  1.1
4 1.5  0.2 12  2 10  4
5 1.6  0.4 22  3 15  4
6 1.6  0.3 19  2 15  4
SB105 W. hellenica 3 1.6  0.1 1.5  0.2 3.0  0.5
4 1.5  0.2 5.8  1.4 12  2
5 1.6  0.2 12  2 20  2
6 1.4  0.3 16  2 16  2
a Data are the mean  SD from three independent experiments.
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ml). Protein content was determined by the Bio-Rad protein assay
kit (Bio-Rad laboratories, Hercules, USA).
2.7. Measurement of the lactic acid content
The amount of lactic acid produced during incubation was
measured using a fast analyzer unit RQﬂex plus 10 and a
Reﬂectoquant Lactic Acid Test (Merck, Darmstadt, Germany).
The assays were based on the coupling reaction catalyzed by
lactate dehydrogenase and diaphorase contained in the test strips
for ﬁnal formation of blue formazan, the concentration of which is
determined reﬂectometrically.
3. Results and discussion
3.1. Screening of LAB producing GABA and their ACE inhibitory activity
We evaluated 53 randomly selected isolates from fermented
foods using MRS medium to identify LAB that produced large
amounts of GABA (Table 1). Of these, 5 isolates were previously
obtained in our past work on narezushi [21]. The identiﬁcation of
strains involved 16S rDNA sequencing, and all strains shared 99%–
100% identity with previously reported nucleotide sequences of
each species. Among the isolates, Lactobacillus was dominant
(35 isolates), and the other were Leuconostoc (eight isolates),
Weissella (ﬁve), Pediococcus (two), Enterococcus (two), and
Carnobacterium (one). These isolates were cultivated in MRS
medium containing 1% (w/v) glutamic acid, and we measured the
GABA concentration in the culture supernatant after ﬁltration. As
shown in Table 2, 10 LAB produced high amounts of GABA at a
concentration of approximately 500 mg/100 ml or even higher
(GABA/glutamic acid molar conversion ratio of >70%). Their 16S
rDNA sequences shared 100% identity with typical strains in each
genus, i.e., Lactobacillus buchneri NRRL B-30929 (GenBank acces-
sion number CP002652.1), Weissella hellenica NCFB2973
(NR_118771.1), and L. brevis ATCC14869 (AZCP01000010.1). We
further investigated the assimilation potential of various sugars (by
using API 50CHL) of these 10 isolates to precisely determine their
taxonomic positions. Eight were the identical species based on
classiﬁcation using the 16S rDNA analyses, whereas SB101 and
SB105 were identiﬁed as Leuconostoc paramesenteroides. The
species W. hellenica has been deﬁned as an individual subgroup
of L. paramesenteroides, and the characteristics of these two species
were very similar [24]. The 16S rDNA sequence analysis clearly
indicated that SB101 and SB105 were assigned to W. hellenica;
therefore, we regarded these isolates as the same species. There
have been no reports so far that W. hellenica could produce GABA. A
total of 8 of 10 isolates (SB21, SB109, AN1-1, AN1-5, AN2-2, AN3-5,
AN4-5, and ANP7-6) were from aji-narezushi (salted and long-term
fermented horse mackerel, Trachurus japonicus, with rice), which is
a traditional fermented food popular in the Noto peninsula in
Ishikawa Prefecture. The other two were from ika-koujizuke
(SB101) and ika-kurozukuri (SB105). The ACE inhibitory activity
(IC50) of the whey cultured with milk protein media using 7 isolates
(AN1-5, ANP7-6, SB109, AN1-1, SB21, SB101, and SB105) was low
( < 1 mg protein/ml), suggesting that these LAB produce a strong
ACE inhibitory peptide by decomposing milk protein during the
fermentation. When these LAB were cultured with soy protein
media, the whey from all isolates showed the ACE inhibitory
activity. However, IC50 of the whey was > 1 mg protein/ml and
higher than that of the whey cultured with milk protein media.
These results suggest that these LAB can utilize vegetable and
animal sources for the production of ACE inhibitors. The
summarized results are also shown in Table 2. All isolatesindicated in Table 2 are selected from different fermented food
samples, so that we mentioned these as strains below.
3.2. GABA production under low pH condition
Yang et al. [25] reported that GABA biosynthesis by LABs is
regulated by pH. Thus, we investigated the effects of different pH
levels (pH 3, 4, 5, and 6) on the production of GABA during
fermentation. The GABA-producing ability of the 10 strains was
determined via a time course analysis of the extracellular GABA
content (in the culture supernatant) (Fig.1). The intracellular GABA
content was remarkably low, which we determined by measuring
the GABA content in the whole biomass of each strain (data not
shown). The initial pH of the medium was adjusted to 3, 4, 5, and 6,
and the pH was adjusted to their initial values every 12 h to
evaluate the effects of different pH level on the GABA productivity.
110 F. Barla et al. / Biotechnology Reports 10 (2016) 105–110As shown in Fig. 1a–j, the productivity reached to 200–800 mg/
100 ml culture per approximately 50 h at neutral pH, which is almost
comparable to that for L. brevis strain OPK-3 reported by Park and Oh
[26]. pH had a marked effect on the GABA-producing ability. When
the pH was adjusted to 3, the growth rate was low in some strains
(data not shown), and the GABA production was signiﬁcantly low
compared with the values obtained when the pHs were adjusted to
4, 5, or 6 (Fig. 1b, AN2-2-L. brevis; 1 g, AN1-1-L. buchneri; 1i, SB101-
W. hellenica; and 1j, SB105-W. hellenica). In particular, one strain
SB105 (Fig. 1j) produced large amounts of GABA only when the pH
was 6, whereas the amount of GABA produced was <100 mg/100 ml
when the pH values were set to 3, 4 or 5. Three strains had a good
ability to produce GABA, regardless of the pH value (Fig.1a, AN1-5-L.
brevis; 1e, ANP7-6-L. brevis; and 1f, SB109-L. brevis). All of these
strains had a strong ability to consume glutamic acid within 96 h of
the start of cultivation, and they produced maximum amounts of
GABAevenwhen the pH was 3. The other two strains(Fig.1d, AN4-5-
L. brevis and 1 h, SB21-L. buchneri) exhibited incomplete production
of GABA at pH 3, although their ability to produce GABA at this pH
was still obvious. In addition, we determined the lactic acid content
of the medium during fermentation (Table 3). Three strains had
lactic acid production levels that were <50% in the culture with pH
3 compared with pH 4–6, which indicated that their viabilities were
reduced under low pH conditions (AN1-1, SB101, and SB105). This
was because of the severe growth retardation effects caused by low
pH, which almost correlated with the amount of GABA produced at
pH 3 (Fig. 1). It is interesting to note that even in the strains that
belonged to the same species, the ability to produce lactic acid
varied over a wide pH range. One L. brevis strain SB109 produced
lactic acid concentrations of >20 g/l at pH 3 within 96 h, whereas
another AN2-2 strain had a weak ability to produce lactic acid and
GABA (Fig. 1 and Table 3). These results suggest that we need to
select the LAB starter at the strain level to prepare fermented foods
derived from the production sources with a low pH.
In conclusion, we showed that LAB isolated from various
fermented foods of the Ishikawa Prefecture of Japan could produce
high amounts of biologically active compounds such as GABA and
ACE inhibitors, which have many potential applications in
functional foods. LAB had a key role in fermentation processes,
and they have a long and safe history of application and
consumption during the production of fermented foods and
beverages. These strains could be used in the future as starters to
produce new types of fermented foods or drinks with signiﬁcant
human health beneﬁts, and they may facilitate the biosynthetic
production of natural GABA. In particular, three L. brevis strains,
AN1-5, ANP7-6, and SB109, had a strong GABA-producing ability at
pH 3; therefore, they could be used effectively during fermented
food production. New functional foods could be made from low pH
production sources such as fruit juices, jam, or vinegar-containing
beverages, which have not previously been used as candidate
sources for LAB fermentation.
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